Your browser doesn't support javascript.
Giant cell myocarditis after first dose of BNT162b2 - a case report.
Hirsch, Valentin G; Schallhorn, Sven; Zwadlo, Carolin; Diekmann, Johanna; Länger, Florian; Jonigk, Danny David; Kempf, Tibor; Schultheiss, Heinz-Peter; Bauersachs, Johann.
  • Hirsch VG; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
  • Schallhorn S; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
  • Zwadlo C; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
  • Diekmann J; Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
  • Länger F; Institute of Pathology, Hannover Medical School, Hannover, Germany.
  • Jonigk DD; Institute of Pathology, Hannover Medical School, Hannover, Germany.
  • Kempf T; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
  • Schultheiss HP; Institute of Cardiac Diagnostics and Therapy, IKDT GmbH, Berlin, Germany.
  • Bauersachs J; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
Eur J Heart Fail ; 24(7): 1319-1322, 2022 07.
Article in English | MEDLINE | ID: covidwho-1898655
ABSTRACT
Herein we report the case of a young man, admitted to the Department of Cardiology and Angiology at Hannover Medical School with shortness of breath and elevated troponin. Few weeks earlier the patient received the first dose of BioNTech's mRNA vaccine (Comirnaty, BNT162b2). After diagnostic work-up revealed giant cell myocarditis, the patient received immunosuppressive therapy. In the present context of myocarditis after mRNA vaccination we discuss this rare aetiology and the patient's treatment strategy in the light of current recommendations.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / BNT162 Vaccine / Myocarditis Type of study: Case report / Etiology study / Observational study Topics: Long Covid / Vaccines Limits: Humans / Male Language: English Journal: Eur J Heart Fail Journal subject: Cardiology Year: 2022 Document Type: Article Affiliation country: Ejhf.2590

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / BNT162 Vaccine / Myocarditis Type of study: Case report / Etiology study / Observational study Topics: Long Covid / Vaccines Limits: Humans / Male Language: English Journal: Eur J Heart Fail Journal subject: Cardiology Year: 2022 Document Type: Article Affiliation country: Ejhf.2590